system
l
major
transport
system
cellular
uptak
neutral
amino
acid
among
system
l
transport
ltype
amino
acid
transport
respons
nutrient
uptak
cancer
cell
wherea
ltype
amino
acid
transport
transport
noncanc
cell
studi
establish
cell
line
stabli
express
high
level
human
form
heterodim
nativ
human
cell
found
l
c
alanin
appropri
substrat
examin
function
wherea
l
c
leucin
use
use
l
c
alanin
first
time
directli
evalu
function
human
express
mammalian
cell
obtain
reliabl
kinet
use
amino
acid
includ
demonstr
group
interfer
interact
cell
line
higher
practic
advantag
would
use
screen
analyz
compound
develop
drug
use
cancer
diagnosi
therapeut
strategi
took
establish
cell
line
would
also
applic
heterodimer
transport
import
therapeut
implic
amino
acid
transport
across
plasma
membran
mediat
via
amino
acid
transport
situat
plasma
membran
amino
acid
transport
origin
describ
amino
acid
transport
system
among
system
l
na
independ
neutral
amino
acid
transport
agenc
major
rout
live
cell
take
neutral
amino
acid
includ
branchedchain
aromat
amino
acid
mean
express
clone
isol
cdna
encod
first
isoform
system
l
transport
name
ltype
amino
acid
transport
follow
furthermor
identifi
second
isoform
system
l
transport
name
ltype
amino
acid
transport
form
heterodim
via
disulfid
bond
heavi
chain
antigen
essenti
proper
target
plasma
membran
normal
tissu
mrna
detect
author
contribut
equal
work
research
fellow
japan
societi
promot
scienc
correspond
author
ykanai
publish
onlin
jstage
juli
advanc
doi
moieti
brain
ovari
testi
placenta
wherea
protein
report
bloodbrain
barrier
placenta
barrier
low
level
regard
cancer
celltyp
transport
highli
upregul
malign
tumor
express
relat
poor
prognosi
patient
cancer
cell
thu
suppos
provid
cancer
cell
neutral
amino
acid
includ
sever
essenti
amino
acid
nutrit
highaffin
inhibitor
develop
antitumor
effect
fact
demonstr
experiment
anim
also
involv
tissueand
cellular
deliveri
amino
acidrel
drug
antiparkinson
drug
ldopa
anticonvuls
gabapentin
antitumor
phenylalanin
mustard
melphalan
substrat
ldopa
gabapentin
suppos
deliv
brain
bloodbrain
barrier
wherea
contribut
transport
melphalan
cancer
cell
recent
propos
l
f
radiotrac
positron
emiss
tomographi
pet
cancer
diagnosi
boronophenylalanin
boron
neutron
captur
therapi
accumul
cancer
cell
express
cancer
cell
indic
applic
cancer
diagnosi
therapeut
contrast
normal
celltyp
transport
wide
express
anim
bodi
includ
small
intestin
kidney
brain
placenta
ovari
testi
skelet
muscl
pancrea
epithelia
small
intestin
renal
proxim
tubul
local
basolater
membran
respons
transepitheli
absorpt
amino
acid
lumin
fluid
blood
well
particip
permeat
amino
acid
amino
acidrel
drug
ldopa
bloodbrain
barrier
placenta
barrier
one
notabl
differ
substrat
select
lie
accept
moieti
accept
substrat
wherea
show
less
interact
aromat
amino
acid
chemic
compound
target
avoid
interact
thu
propos
drug
candid
cancer
diagnosi
therapeut
recent
shown
upregul
noncanc
lesion
thu
inhibitor
might
also
consid
therapeut
develop
drug
screen
chemic
compound
essenti
establish
vitro
simpl
assay
system
analyz
interact
separ
howev
establish
cell
line
stabli
express
heterodimer
transport
suffer
difficulti
firstli
host
cell
line
origin
express
endogen
heterodimer
complex
overexpress
exogen
expel
endogen
form
heterodim
appear
cell
surfac
amount
endogen
limit
level
cell
surfac
express
exogen
would
difficult
obtain
high
level
function
activ
even
overexpress
secondli
host
cell
mock
cell
exhibit
high
level
system
l
activ
due
endogen
heterodim
difficult
distinguish
exogen
introduc
endogen
activ
previous
gener
mous
cell
line
stabli
express
human
cell
human
cell
cell
chosen
easi
host
cell
establish
stabli
transfect
cell
line
evalu
express
function
use
l
c
leucin
substrat
lleucin
common
substrat
l
c
leucin
uptak
cell
measur
na
free
medium
suppos
mediat
exogen
express
human
human
respect
although
contribut
l
c
leucin
uptak
cell
confirm
inhibitor
l
c
leucin
uptak
cell
prove
directli
inhibitor
avail
moment
addit
cell
requir
variou
growth
factor
less
common
cultur
medium
maintain
desir
largescal
screen
chemic
compound
concern
cell
exogen
introduc
human
human
form
heterodim
endogen
mous
studi
overcom
disadvantag
cell
cell
use
convent
human
embryon
kidney
host
cell
establish
new
cell
line
stabli
express
high
level
human
human
search
appropri
substrat
evalu
function
compar
l
c
leucin
addit
use
newli
establish
valid
cell
line
assay
examin
differenti
interact
moieti
introduc
wider
spectrum
compound
chemic
use
studi
analyt
fig
cell
obtain
hsrrb
osaka
maintain
minimum
essenti
medium
mem
wako
contain
vv
heatinactiv
fetal
bovin
serum
invitrogen
san
diego
ca
usa
supplement
nonessenti
amino
acid
wako
humid
co
fulllength
cdna
human
genbankemblddbj
access
human
genbankemblddbj
access
subclon
mammalian
express
vector
invitrogen
obtain
respect
cell
seed
onto
dish
densiti
cellsdish
cultur
h
confluenc
cell
transfect
vector
use
lipofectamin
tm
invitrogen
accord
manufactur
instruct
h
transfect
cell
subcultur
plate
contain
cultur
medium
supplement
gl
cell
seed
rang
cell
per
plate
obtain
individu
coloni
cultur
medium
chang
everi
day
week
singl
coloni
visual
coloni
form
singl
coloni
isol
use
clone
cylind
cell
isol
clone
trypsin
min
cell
transfer
plate
contain
cultur
medium
supplement
cell
subcultur
plate
subsequ
plate
maintain
presenc
l
c
leucin
uptak
measur
clone
cell
stabli
express
human
clone
cell
stabli
express
human
among
clone
test
clone
show
higher
l
c
leucin
uptak
compar
cell
stabli
transfect
vector
plasmid
select
final
select
reli
stabil
uptak
activ
passag
hela
cell
cell
cultur
describ
elsewher
isol
total
rna
cell
cultur
monolay
dish
confluenc
cell
wash
pb
lyse
ml
isogen
nippon
gene
tokyo
rna
isol
perform
follow
manufactur
instruct
firststrand
cdna
stabl
cell
line
gener
util
superscript
tm
iii
revers
transcriptas
invitrogen
specif
primer
design
correspond
sequenc
genbankembl
ddbj
access
crude
membran
prepar
cell
cultur
plate
confluenc
collect
suspend
buffer
contain
mm
trishcl
ph
mm
nacl
mm
edta
mm
phenylmethylsulfonyl
fluorid
mm
na
vo
mm
naf
cell
disrupt
ultrason
icecold
water
cell
debri
separ
centrifug
g
min
supernat
ultracentrifug
g
min
centrifug
crude
membran
pellet
lyse
mm
trishcl
ph
mm
nacl
mm
edta
mm
phenylmethylsulfonyl
fluorid
protein
concentr
measur
bca
protein
assay
thermo
fisher
scientif
waltham
usa
lysat
mix
laemmli
sampl
buffer
reduc
condit
without
nonreduc
condit
mm
dithiothreitol
dtt
subject
sdspage
plasma
membran
fraction
prepar
describ
previous
minor
modif
cell
pellet
suspend
homogen
buffer
contain
mm
trishcl
ph
mm
sucros
mm
nacl
mm
edta
proteas
inhibitor
cocktail
roch
appli
scienc
indianapoli
usa
cell
homogen
centrifug
g
min
supernat
centrifug
g
hitachi
rotor
hitachi
koki
tokyo
min
membran
pellet
resuspend
ml
iodixanol
solut
mm
trishcl
ph
mm
edta
wv
iodixanol
axisshield
poc
oslo
norway
mm
sucros
membran
suspens
overlay
ml
iodixanol
solut
sequenti
centrifug
g
beckman
ti
rotor
beckman
coulter
brea
ca
usa
h
one
millilit
fraction
collect
top
fraction
analyz
sdspage
western
blot
confirm
western
blot
plasma
membran
marker
organel
marker
fraction
iodixanol
interfac
pool
plasma
membran
fraction
protein
concentr
measur
bca
protein
assay
membran
fraction
dissolv
affymetrix
santa
clara
ca
usa
mix
laemmli
sampl
buffer
subject
sdspage
sdspage
separ
protein
transfer
electrophoret
hybondp
pvdf
transfer
membran
ge
healthcar
life
scienc
pittsburgh
pa
usa
membran
preblock
block
solut
wv
skim
milk
room
temperatur
h
membran
incub
block
solut
contain
dilut
antibodi
either
affinitypurifi
rabbit
cterminu
polyclon
antibodi
rabbit
antiserum
amino
acid
residu
antibodi
santa
cruz
biotechnolog
santa
cruz
ca
usa
membran
treat
horseradishperoxidaseconjug
antirabbit
igg
jackson
immunoresearch
laboratori
west
grove
pa
usa
secondari
antibodi
signal
develop
use
immobilon
western
chemiluminesc
hrp
substrat
millipor
billerica
usa
visual
mini
luminesc
imag
analyz
fujifilm
tokyo
cell
harvest
dish
lyse
lysi
buffer
mm
trishcl
ph
mm
nacl
mm
edta
triton
proteas
inhibitor
cocktail
roch
appli
scienc
cell
lysat
incub
overnight
either
control
mous
igg
santa
cruz
monoclon
antibodi
provid
dr
yasuhiko
ito
chubu
univers
lysat
mix
dynabead
protein
g
invitrogen
incub
h
rotat
bead
wash
lysi
buffer
resuspend
laemmli
sampl
buffer
sampl
heat
min
subject
sdspage
separ
protein
detect
western
blot
describ
function
clone
stabl
cell
line
analyz
uptak
experi
describ
previous
briefli
cell
seed
densiti
cellswel
onto
collagenco
plate
cell
use
uptak
experi
two
day
seed
cell
reach
approxim
confluenc
remov
cultur
medium
cell
care
wash
prewarm
na
free
hbss
hank
balanc
salt
solut
contain
mm
chlorin
chlorid
mm
kcl
mm
mgso
mm
kh
po
mm
cacl
mm
glucos
mm
hepe
ph
preincub
prewarm
na
free
hbss
min
ad
substrat
uptak
experi
cell
incub
min
uptak
medium
na
free
hbss
contain
l
c
leucin
mbqmmol
l
c
alanin
mbqmmol
subsequ
cell
wash
three
time
icecold
na
free
hbss
cell
lyse
n
naoh
lysat
mix
ml
emulsifi
safe
cocktail
perkinelm
waltham
usa
radioact
measur
counter
aloka
tokyo
inhibit
experi
uptak
l
c
leucin
l
c
alanin
examin
presenc
absenc
mm
nonradiolabel
test
compound
compound
dmso
use
examin
inhibitori
effect
uptak
l
c
leucin
l
c
alanin
due
low
solubl
compound
uptak
measur
min
within
linear
rage
time
depend
uptak
l
c
leucin
l
c
alanin
obtain
k
v
max
valu
transport
uptak
substrat
measur
kinet
paramet
k
v
max
k
determin
nonlinear
regress
program
sigmaplot
systat
softwar
chicago
il
usa
experi
perform
replic
data
express
mean
sem
statist
differ
determin
use
unpair
student
ttest
differ
consid
signific
p
human
cell
line
establish
studi
stabli
express
human
human
respect
clone
select
higher
uptak
confirm
endogen
cell
form
heterodim
exogen
express
immunoprecipit
antihuman
monoclon
antibodi
fig
shown
right
panel
fig
antibodi
success
precipit
endogen
cell
lane
coimmunoprecipit
detect
mock
cell
predominantli
cell
accumul
coimmunoprecipit
made
cell
detect
fig
left
panel
lane
coprecipit
cell
wherea
cell
show
band
fig
middl
panel
lane
coprecipit
control
igg
lane
panel
fig
level
express
plasma
membran
compar
stabl
cell
line
establish
present
studi
cell
gener
previous
cell
shown
fig
cell
show
larger
amount
plasma
membran
compar
cell
wherea
level
similar
cell
cell
fig
properti
uptak
l
c
leucin
l
c
alanin
compar
among
cell
l
c
leucin
uptak
cell
higher
cell
stabl
clone
exhibit
higher
l
c
leucin
uptak
select
screen
clone
fig
l
c
leucin
uptak
cell
inhibit
classic
system
l
inhibitor
acid
bch
fig
present
studi
furthermor
measur
l
c
alanin
uptak
lalanin
good
substrat
indic
fig
cell
show
high
level
l
c
alanin
uptak
contrast
l
c
alanin
uptak
cell
quit
low
fig
uptak
l
c
leucin
cell
l
c
alanin
cell
exhibit
linear
depend
incub
time
first
min
data
shown
thu
uptak
measur
conduct
min
uptak
l
c
leucin
cell
l
c
alanin
cell
satur
follow
michaelismenten
kinet
fig
kinet
paramet
uptak
list
tabl
michaelismenten
curv
show
similar
k
valu
cell
uptak
l
c
leucin
cell
l
c
alanin
cell
measur
presenc
mm
nonradiolabel
lamino
acid
fig
uptak
l
c
leucin
cell
inhibit
higher
level
lmethionin
lleucin
lisoleucin
lvalin
lphenylalanin
ltyrosin
ltryptophan
lhistidin
bch
lower
level
lalanin
lserin
lthreonin
lcystein
lasparagin
lglutamin
fig
glycin
lprolin
lcystin
basic
amino
acid
llysin
larginin
acid
amino
acid
lglutam
laspart
caus
littl
inhibit
l
c
leucin
uptak
cell
similar
inhibit
profil
obtain
mock
cell
data
shown
l
c
alanin
uptak
cell
strongli
inhibit
neutral
amino
acid
lhistidin
bch
wherea
lprolin
lcystin
llysin
larginin
lglutam
laspart
inhibit
l
c
alanin
uptak
fig
noteworthi
stablytransfect
cell
line
show
profil
inhibit
amino
acid
even
passag
recov
frozen
stock
liquid
nitrogen
data
shown
amino
acid
deriv
also
examin
inhibitori
effect
cell
shown
fig
one
bulki
side
chain
thyroxin
inhibit
uptak
l
c
leucin
cell
wherea
inhibit
uptak
l
c
alanin
cell
amino
acid
mm
strongli
inhibit
uptak
l
c
leucin
cell
wherea
weakli
inhibit
uptak
l
c
alanin
cell
fig
inhibit
l
c
alanin
uptak
cell
promin
less
ldopa
fig
level
inhibit
similar
cell
although
inhibit
l
c
leucin
uptak
cell
rel
less
fig
effect
examin
lalanin
good
substrat
inhibit
l
c
alanin
uptak
cell
less
lalanin
fig
furthermor
inhibit
significantli
less
p
figur
illustr
concentrationdepend
inhibit
l
concentrationdepend
manner
fig
similarli
lalanin
bch
concentrationdepend
inhibit
l
c
alanin
uptak
fig
ic
valu
lleucin
bch
inhibit
l
c
leucin
uptak
respect
cell
ic
valu
lalanin
bch
inhibit
l
c
alanin
uptak
respect
effect
bch
examin
concentr
depend
l
c
leucin
uptak
l
c
alanin
uptak
shown
fig
c
f
bch
shift
concentrationdepend
curv
l
c
leucin
uptak
l
c
alanin
uptak
inhibit
kinet
bch
well
lleucin
lalanin
fit
competit
inhibit
nonlinear
regress
analysi
also
confirm
lineweaverburk
plot
data
shown
k
valu
list
tabl
k
valu
approxim
studi
establish
human
cell
line
stabli
express
human
human
use
cell
host
cell
endogen
express
cell
lower
human
cell
line
gener
avail
laboratori
data
shown
properti
benefici
reduc
background
amino
acid
transport
avoid
contamin
endogen
activ
particularli
cell
confirm
rtpcr
western
blot
use
antibodi
exogen
transfect
express
high
level
cell
fig
b
fact
protein
level
cell
higher
hela
fig
one
cell
line
highest
express
furthermor
predomin
band
correspond
heterodim
exogen
introduc
endogen
cell
detect
nonreduc
condit
fig
coimmunoprecipit
use
antibodi
fig
suggest
exogen
introduc
appear
cell
surfac
form
heterodim
endogen
essenti
cell
surfac
local
overexpress
exogen
introduc
endogen
cell
would
compet
abl
form
heterodim
exogen
introduc
would
predomin
partner
plasma
membran
therefor
cell
line
gener
present
studi
propos
almost
exclus
express
exogen
introduc
partner
endogen
cell
surfac
avoid
surfac
express
endogen
cell
also
advantag
consid
format
heterodim
human
human
compar
cell
gener
previous
use
mous
cell
line
heterodim
mous
human
form
although
contribut
function
partner
transport
defin
moment
heterodim
human
human
would
desir
evalu
function
human
clone
cell
select
screen
higher
uptak
substrat
show
high
level
express
level
express
plasma
membran
fraction
cell
much
higher
cell
fig
level
express
plasma
membran
fraction
cell
similar
cell
highli
express
fig
screen
cell
clone
higher
substrat
uptak
function
eventu
abl
obtain
clone
quit
high
protein
level
fig
could
explain
reason
cell
clone
higher
surfac
level
obtain
addit
aforement
benefit
form
heterodim
human
human
cell
establish
present
studi
compar
previous
gener
cell
benefit
lower
background
host
cell
higher
level
express
transfect
cell
surfac
easier
handl
establish
cell
line
due
simpl
convent
cultur
medium
requir
mainten
cell
somewhat
stabl
express
transfect
properti
would
advantag
cell
use
screen
chemic
compound
interact
well
kinet
analysi
interact
previou
studi
conduct
cell
use
l
c
leucin
substrat
character
function
properti
stabli
express
cell
line
examin
interact
chemic
compound
host
mock
cell
take
l
c
leucin
due
endogen
complex
plasma
membran
also
inhibitor
present
avail
difficult
cell
evalu
contribut
exogen
express
l
c
leucin
uptak
cell
studi
found
l
c
alanin
appropri
substrat
evalu
function
exogen
express
cell
l
c
alanin
uptak
mock
host
cell
quit
low
wherea
cell
exhibit
remark
high
l
c
alanin
uptak
fig
contrast
l
c
alanin
uptak
cell
low
fig
clearli
indic
l
c
alanin
specif
cell
na
free
condit
l
c
alanin
desir
substrat
evalu
function
introduc
cell
use
cell
l
c
alanin
substrat
present
studi
succeed
first
time
evalu
directli
function
human
express
mammalian
cell
obtain
reliabl
kinet
paramet
transport
k
valu
lalanin
uptak
determin
studi
use
cell
agre
report
express
xenopu
oocyt
similarli
k
valu
lleucin
measur
cell
rather
report
cell
correspond
obtain
use
xenopu
oocyt
express
system
propos
l
c
alanin
uptak
measur
cell
enabl
accur
function
evalu
cultur
cell
reliabl
estim
interact
chemic
compound
inhibit
profil
cell
cell
obtain
studi
fig
b
basic
similar
report
previous
examin
xenopu
oocyt
consist
idea
endogen
cell
associ
exogen
introduc
cell
respect
thu
transport
function
stabli
transfect
cell
line
reflect
properti
exogen
introduc
report
cell
xenopu
oocyt
express
system
thyroid
hormon
aromat
amino
acid
select
compar
cell
fig
b
experiment
scheme
valid
present
studi
measur
kinet
paramet
human
human
inhibit
human
human
concentrationdepend
manner
k
valu
respect
fig
tabl
demonstr
first
time
quantit
manner
select
studi
furthermor
examin
effect
wider
spectrum
amino
acid
includ
studi
far
confirm
interact
moieti
fig
contrast
less
interact
moieti
although
lalanin
strongli
inhibit
uptak
deriv
inhibit
weakli
fig
interact
less
compar
suggest
bulki
interfer
interact
thu
natur
accept
moieti
confirm
use
deriv
substrat
also
first
demonstr
group
interfer
interact
amino
acid
studi
also
measur
k
valu
bch
cell
show
bch
select
compar
fig
tabl
sinc
bch
origin
develop
system
l
inhibitor
christensen
cowork
differenti
sensit
system
l
isoform
bch
consid
quantit
bch
fact
regard
gener
inhibitor
system
l
previou
studi
use
cell
examin
effect
bch
obtain
k
valu
indic
bch
select
confirm
experiment
scheme
valid
present
studi
conclud
bch
vivo
studi
bch
use
inhibit
express
cancer
bch
suppress
cancer
growth
less
side
effect
could
explain
natur
bch
shown
upregul
tumor
cell
suppli
tumor
cell
amino
acid
support
continu
growth
prolifer
contrast
essenti
amino
acid
suppli
noncanc
cell
epitheli
transport
amino
acid
small
intestin
kidney
therefor
develop
inhibitor
substrat
affect
import
therapeut
diagnost
implic
inhibitor
would
suppress
tumor
cell
growth
reduc
amino
acid
suppli
tumor
cell
could
use
antitumor
agent
less
side
effect
nontumor
cell
furthermor
substrat
expect
select
taken
accumul
tumor
cell
could
use
probe
cancer
diagnosi
pet
singl
photon
emiss
comput
tomographi
spect
l
f
f
famt
l
imt
aromat
amino
acid
use
pet
spect
respect
radiotrac
quit
benefici
compar
convent
use
glucos
analogu
pet
tracer
f
f
fdg
amino
acid
pet
tracer
differenti
malign
tumor
benign
lesion
well
reduc
physiolog
background
imag
substrat
could
also
use
treatment
cancer
compound
taken
cell
via
exert
antitumor
effect
melphalan
phenylalanin
mustard
boronophenylalanin
use
boron
neutron
captur
therapi
deliveri
amino
acidrel
drug
though
bloodbrain
barrier
would
advantag
design
drug
transport
exist
barrier
vitro
simpl
assay
system
develop
valid
studi
would
use
gener
drug
interact
andor
summari
establish
human
cell
line
stabli
express
high
level
heterodimer
complex
human
human
amino
acid
transport
cell
surfac
furthermor
establish
reliabl
assay
investig
interact
transport
chemic
compound
cell
line
maintain
convent
cultur
medium
could
also
use
screen
compound
develop
drug
specif
andor
desir
pharmacodynam
pharmacokinet
addit
strategi
took
studi
establish
cell
line
stabli
express
heterodimer
transport
would
also
applic
heterodimer
transport
drug
target
member
heterodimer
transport
would
also
import
clinic
implic
